Navigation Links
Reducing The Risk Of Fractures After a Heart Transplant

People who undergo a heart transplant usually lose significant bone mass in the first year after the transplant, mainly due to // the powerful drugs that keep their bodies from rejecting the new organ. The bone loss greatly increases their risk for fractures. Studies suggest the prevalence of fractures among this group ranges from 22 percent to 44 percent. Preventing bone loss is a primary goal of treatment, but which drugs work best in this situation is unclear.

In a study done researchers assigned 149 transplant patients to receive treatment with either the bisphosphonate drug alendronate or calcitriol, a form of vitamin D. All began the therapy about a month after their transplant. At a one-year follow up, patients on alendronate had a reduction in bone mineral density at the lumbar spine of 0.7 percent. The calcitriol group had a reduction of 1.6 percent. BMD decreased by 1.7 percent at the femoral neck for the alendronate patients and 2.1 percent for the calcitriol patients. The rate of fractures was about the same for the two groups.

A comparison of the treatment groups with a similar group of patients receiving no treatment for bone loss indicates both treatments help prevent bone loss . However, significantly more of the calcitriol patients than the alendronate patients -- 27 percent vs. 7 percent -- also developed a condition known as hypercalciuria, which is excessive loss of calcium in the urine

Thus based on these studies researchers conclude that alendronate is the better treatment for bone loss among people who have undergone a heart transplant.
'"/>




Page: 1

Related medicine news :

1. Reducing Lung Cancer Risk
2. Reducing the risk for type 2 diabetes
3. Reducing Medication Errors
4. Reducing HIV Transmission
5. Reducing Pain from Knee Surgery
6. Reducing Pain From Knee Surgery
7. Reducing The After Effects of Tonsillectomy
8. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
9. Reducing Number Of Cigarettes Not Enough
10. Drug Found Effective In Reducing Vertebral Fractures In Women
11. Reducing TB With Ultraviolet Light
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... imaging practices, is seeking candidates to serve on its Accreditation and Standards ... , “RadSite’s ultimate mission is improving image quality and reducing patient radiation ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... ... ... During April 21-23, Super-Sod will join the vendor market of the Sacred Heart ... from the avid gardener to the landscape admirer — during the three-day schedule. , ... grand venue, and we are certainly looking forward to participating in this year’s festival,” ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... Service Provider, announces a significant bandwidth upgrade infrastructure service to Tele-Media Solutions. ... Solutions. One of IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: